Nathan D. Hatton
( out of 54 reviews )

Nathan D. Hatton, MD

Languages spoken: English

Clinical Locations

Primary Location

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-581-2000
Get Directions

Cardiovascular Center

Cardiovascular Center
50 N Medical Dr
Salt Lake City , UT 84132
801-585-7676
Get Directions

Nathan D. Hatton, M.D. is a Professor of Medicine at the University of Utah School Of Medicine. He grew up in a small Indiana community before completing his undergraduate education at Hanover College. He subsequently attended Indiana University where he obtained a masters degree in physiology and biophysics prior to attending medical school. He received his medical degree from Indiana University prior to moving to Utah for his training in Internal Medicine at University Of Utah. He completed a Pulmonary Medicine and Critical Care Medicine fellowship at the University of Utah. Upon completion of his fellowship he joined the faculty at the University of Utah in 2009.

He served as the Associate Medical Director of the Medical Intensive Care Unit at the University Hospital from 2012 to 2017. His current hospital based responsibilities include attending in the Medical Intensive Care Unit at University Hospital and focusing on housestaff and nursing education. His outpatient clinical care focuses on general pulmonary diseases along with patients with pulmonary hypertension. He is the co-director of the Pulmonary Hypertension Dyspnea Center at the University of Utah. He also has directed the second year medical student pulmonary medicine curriculum for the past decade. He has recently been promoted to the pulmonary core educator with in the University of Utah Medical school overseeing the entire four year pulmonary curriculum. Most recently, he has been an intricate part in the planning and management of the SARS-2-CoV pandemic at the University of Utah hospital. For this project, he has applied continuous critical care experience taking care of COVID19 patients since March 2020 to assist in study design. His experiences are most helpful in assessing key clinical annotations that may be helpful in understanding the plausibility of different biological pathways that underlie our deep clinical experience. For example, to consider how the different SARS-CoV-2 variants affect specific findings related to respiratory failure which may be plausible modifiers of biological pathways that underlie poor outcomes. Of course, he overseeing the collection of simultaneous upper airway and tracheal samples to enable the multiple laboratory measurements that make this project novel, compelling and generalizable.

Specialties

Board Certification

American Board of Internal Medicine (Sub: Pulmonary Disease)
American Board of Internal Medicine (Sub: Critical Care Medicine)

Patient Rating

4.9 /5
( out of 54 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

SUGAR HOUSE HEALTH CENTER

Dr Hatton knows my case especially well, Jenelle also very friendly and courteous and knowledgeable.

SUGAR HOUSE HEALTH CENTER

Dr Hatton is the best ever. He has stuck with me when everyone else threw in the towel. I will always have a greate appreciation for him.

SUGAR HOUSE HEALTH CENTER

I was totally comfortable and felt his concern, skill and desire to help me feel better. I was ENCOURAGED

SUGAR HOUSE HEALTH CENTER

I felt listened to, I didn't feel there was a rush to go on to the next patient, I felt my time and input were valued.

SUGAR HOUSE HEALTH CENTER

Dr Hatton and Jennalyn listen and take very good care of me. They are genuine in their care for me.

SUGAR HOUSE HEALTH CENTER

Made me feel like I had his total focus

SUGAR HOUSE HEALTH CENTER

After carefully reviewing all of my tests, Dr. Hatton was able to ease my concerns of a potentially devastating outcome which was ruled out. Together we discussed strategies moving forward.

SUGAR HOUSE HEALTH CENTER

Dr Hatton is incredible! He spends the most amount of time with me of all my doctors. He really checks in on how I am doing and is extremely patient in answering all of my questions and helping me understand.

SUGAR HOUSE HEALTH CENTER

Dr. Hatton is a great listener! Doesn't act like he is in a hurry. Seems like he really cares and really wants to make sure that all my needs are met and all my questions answered. I would recommend him to anyone who is fed up with docs that treat you like a number . Dr. Hatton is amazing and is a great help in my time of need!

Nathan D. Hatton, M.D. is a Professor of Medicine at the University of Utah School Of Medicine. He grew up in a small Indiana community before completing his undergraduate education at Hanover College. He subsequently attended Indiana University where he obtained a masters degree in physiology and biophysics prior to attending medical school. He received his medical degree from Indiana University prior to moving to Utah for his training in Internal Medicine at University Of Utah. He completed a Pulmonary Medicine and Critical Care Medicine fellowship at the University of Utah. Upon completion of his fellowship he joined the faculty at the University of Utah in 2009.

He served as the Associate Medical Director of the Medical Intensive Care Unit at the University Hospital from 2012 to 2017. His current hospital based responsibilities include attending in the Medical Intensive Care Unit at University Hospital and focusing on housestaff and nursing education. His outpatient clinical care focuses on general pulmonary diseases along with patients with pulmonary hypertension. He is the co-director of the Pulmonary Hypertension Dyspnea Center at the University of Utah. He also has directed the second year medical student pulmonary medicine curriculum for the past decade. He has recently been promoted to the pulmonary core educator with in the University of Utah Medical school overseeing the entire four year pulmonary curriculum. Most recently, he has been an intricate part in the planning and management of the SARS-2-CoV pandemic at the University of Utah hospital. For this project, he has applied continuous critical care experience taking care of COVID19 patients since March 2020 to assist in study design. His experiences are most helpful in assessing key clinical annotations that may be helpful in understanding the plausibility of different biological pathways that underlie our deep clinical experience. For example, to consider how the different SARS-CoV-2 variants affect specific findings related to respiratory failure which may be plausible modifiers of biological pathways that underlie poor outcomes. Of course, he overseeing the collection of simultaneous upper airway and tracheal samples to enable the multiple laboratory measurements that make this project novel, compelling and generalizable.

Board Certification and Academic Information

Academic Departments Internal Medicine -Professor (Clinical)
Academic Divisions Public Health
Board Certification
American Board of Internal Medicine (Sub: Pulmonary Disease)
American Board of Internal Medicine (Sub: Critical Care Medicine)

Education history

Undergraduate Biology - Hanover College B.A.
Graduate Training Physiology - Indiana University M.A.
Professional Medical Medicine - Indiana University School of Medicine M.D.
Internship Internal Medicine - University of Utah School of Medicine Intern
Residency Internal Medicine - University of Utah School of Medicine Resident
Fellowship Pulmonary/Critical Care - University of Utah School of Medicine Fellow

Selected Publications

Journal Article

  1. Jin N, Hatton N, Swartz DR, Xia Xl, Harrington MA, Larsen SH, Rhoades R (2000). Hypoxia activates jun-N-terminal kinase, extracellular signal-regulated protein kinase, and p38 kinase in pulmonary arteries. American journal of respiratory cell and molecular biology, 23(5), 593-601.
  2. Edholm K, Lappé K, Kukhareva P, Hopkins C, Hatton ND, Gebhart B, Nyman H, Signor E, Davis M, Kawamoto K, Johnson S (2020). Reducing Diabetic Ketoacidosis Intensive Care Unit Admissions Through an Electronic Health Record-Driven, Standardized Care Pathway. Journal for healthcare quality, 42(5), e66-e74.
  3. Mayeux JD, Pan IZ, Dechand J, Jacobs JA, Jones TL, McKellar SH, Beck E, Hatton ND, Ryan J (2021). Management of Pulmonary Arterial Hypertension. Current cardiovascular risk reports, 15(1), 2.
  4. Ciarkowski CE, Timbrook TT, Kukhareva PV, Edholm KM, Hatton ND, Hopkins CL, Thomas F, Sanford MN, Igumnova E, Benefield RJ, Kawamoto K, Spivak E (2020). A Pathway for Community-Acquired Pneumonia With Rapid Conversion to Oral Therapy Improves Health Care Value. Open forum infectious diseases, 7(11), ofaa497.
  5. Selzman CH, Tonna JE, Pierce J, Vargas C, Skidmore C, Lewis G, Hatton ND, Phillips J (2021). A pilot trial of human amniotic fluid for the treatment of COVID-19. BMC research notes, 14(1), 32.
  6. Ingram D, Alamri AK, Penn BA, Mayeux JD, Ma CL, Clapham KR, Abraham AE, Klanderud D, Sadeh B, Beck EM, Hatton ND, Ryan J (2022). Characteristics of Patients With Pulmonary Arterial Hypertension in a Pulmonary Hypertension Association-Accredited Comprehensive Care Center: A Contrast in Features When Compared With US National Registry Data. Cureus, 14(11), e31764.
  7. Tonna JE, Pierce J, Hatton N, Lewis G, Phillips JD, Messina A, Skidmore CR, Taylor K, Selzman C (2021). Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial. BMJ open, 11(2), e045162.
  8. Liou TG, Adler FR, Cahill BC, Cox DR, Cox JE, Grant GJ, Hanson KE, Hartsell SC, Hatton ND, Helms MN, Jensen JL, Kartsonaki C, Li Y, Leung DT, Marvin JE, Middleton EA, Osburn-Staker SM, Packer KA, Shakir SM, Sturrock AB, Tardif KD, Warren KJ, Waddoups LJ, Weaver LJ, Zimmerman E, Paine (2020). SARS-CoV-2 Innate Effector Associations and Viral Load in Early Nasopharyngeal Infection.

Review

  1. Tsarova K, Morgan AE, Melendres-Groves L, Ibrahim MM, Ma CL, Pan IZ, Hatton ND, Beck EM, Ferrel MN, Selzman CH, Ingram D, Alamri AK, Ratcliffe MB, Wilson BD, Ryan J (2022). Imaging in Pulmonary Vascular Disease-Understanding Right Ventricle-Pulmonary Artery Coupling. Comprehensive Physiology, 12(4), 3705-3730.

Case Report

  1. Pan IZ, Carey JR, Jacobs JA, Dechand J, Sessions JJ, Sorensen T, Penn BA, Mayeux JD, Hatton ND, Ryan J (2020). Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension. Frontiers in medicine, 7, 81.

Editorial

  1. Beck EM, Hatton ND, Ryan J (2019). Novel techniques for advancing our understanding of pulmonary arterial hypertension. The European respiratory journal, 53(5),
  2. Gilbertson EA, Hatton ND, Ryan J (2020). Point of care ultrasound: the next evolution of medical education. Annals of translational medicine, 8(14), 846.

Letter

  1. Liou TG, Adler FR, Hatton N (2021). The Uncertain Role of Corticosteroids in the Treatment of COVID-19. JAMA internal medicine, 181(1), 139-140.

News & Podcasts

Podcasts